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This study compares the  hypolipidaemic  effects  of  the increasing  dosages of  A. cepa,  A. sativum  
and  Z. officinale  aqueous  extract  on  alloxan-diabetic  Rattus  novergicus  for possible use in the 
management  of hyperlipidaemia characteristic  of diabetes mellitus. Diabetes mellitus was induced in 
108 out of a total of 117 adult Rattus novergicus   using 150mg/kg b wt of alloxan monohydrate. 
Increasing dosages (200, 250 and 300mg/kg bw ip) of A. cepa, A. sativum and Z. officinale  aqueous  
extracts were given to the diabetic rats for six weeks while the control rats  got either normal saline (1ml) 
or  increasing dosage of glibenclamide ( 2.5, 3.8 and 5.0mg/kg b wt ip) during the same period. Total 
serum lipids and total serum cholesterol were assessed using routine methods. Increasing dosages of 
plants aqueous  extracts produced  a dose-dependent significant (P < 0.05)  reductions  in the total  
serum lipid  and  total  serum  cholesterol of diabetic rats.  The  most  effective percentage reduction in  
total  serum  lipids and total  serum  cholesterol  were  observed at 300mg/kg bw ip  and this  was the 
same for  the  three extracts  studied. A. cepa and A. sativum at 300mg/kg bw ip caused significant 
reductions in total serum lipids more effective than the diabetic control drug glibenclamide at 5.0 mg/kg 
bw ip.  A. cepa at 300mg/kg bw ip  was  the  most  effective in  reducing  total serum lipids,  reducing  it  
by  44.4% (184.3 ± 8.4 to 129.7 ± 5.7).  A. sativum at 300mg/kg bw ip  was  the  most  effective in  reducing  
total serum  cholesterol, 39.8%, that was from ( 128.7 ± 2.7 to 77.2 ± 4.9),  A. cepa  followed  27.2% (130.1 
± 3.7 to 94.7 ± 4.2)  and  Z. Officinale was next , 16.1%  from (130.7 ± 4.4 to 109.7 ± 7.5). From our 
experimental findings, it can be concluded that the three plant extracts studied exhibited promising 
hypolipidaemic activity in alloxan-diabetic rats. The hypolipidaemic effect presents a protective 
mechanism against the development of atherosclerosis and hyperlipidaemia common in diabetes 
mellitus. Further studies on the extracts, their composition, mode of action and active ingredients are 
suggested. A research on the combined effects of the three plant extracts on hyperlipidaemia was 
recommended for future investigations.  
 





The term diabetes mellitus describes a metabolic 
disorder of multiple aetiology characterized by 
chronic hyperglycaemia (high blood sugar)  with 
disturbances of carbohydrate, fat and protein 
metabolism resulting from defects in insulin 
secretion, insulin action or both (WHO, 1999). The 
effect of diabetes mellitus includes long-term 
damage, dysfunction and failure of various organs. 
Diabetes mellitus may present characteristic 
symptoms such as thirst, polynuria, blurring of 
vision and weight loss (WHO, 1999). In its most 
severe forms, ketoacidosis or non-ketotic 
hyperosmolar state may develop and lead to stupor, 
coma and in absence of effective treatment death 
(WHO, 1999). Diabetes mellitus was characterized 
by recurrent or persistent hyperglycaemia and other 
signs, as distinct from a single illness or condition. 
WHO (1999) reported that diabetes mellitus can be 
diagnosed by demonstrating any one of the 
following:  
I. fasting plasma glucose level at or above 
126mg/dl (7.0mmol/l).  
II. plasma glucose at or above 200mg/dL or 
11.1mmol/l two hours after a 75g oral 
glucose load as in a glucose tolerance 
test.  
III. random plasma glucose at or above 
200mg/dl or 11.1mmmol/l. 
In 2006, according to the World Health 
Organization, at least 171 million people world wide 
suffer from diabetes (ADA, 2005). Its incidence was 
increasing rapidly and it was estimated that by the 
year 2030, this number will double (ADA, 2005). 
Diabetes was a common and very prevalent 
disease affecting the citizens of both developed and 
developing countries (Erasto et al., 2005). The 
greatest increase in prevalence was however 
expected to occur in Asia and Africa, where more 
patients will likely be found by 2030. In 2005, there 
are about 20.8 million people with diabetes in the 
United States alone. ADA (2005) reported that there 
are about 6.2 million people undiagnosed and about 
41 million people that would be considered pre-
diabetic. The national diabetes information clearing 
house estimates that diabetes costs 132 billion 
dollar in the United States alone every year. ADA 
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(2005) pointed out that 1 in 3 Americans born after 
year 2000 will develop diabetes in their lifetime. 
Statistical projections from India suggested that the 
number of diabetes will rise from 15 million in 1995 
to 57million in the year 2025 making India the 
country with the highest number of diabetics in the 
world (King et al., 1998; Boyle et al., 2001). 
Although there was a paucity of data on the 
prevalence of diabetes in Nigeria and other African 
countries, available data suggested that diabetes 
was emerging as a major health problem in Africa 
(Mbanya et al., 1996). The prevalence of diabetes 
in Nigeria was estimated to be between 1.4 to 2.7% 
of the population (Erasmus et al., 1988; Ngumah, 
1995; Bakari et al., 1999) and over 90% of these 
are non–insulin dependent diabetes mellitus 
(Ohwworiole et al., 1988). Diabetes mellitus has 
been reported to be the major cause of blindness, 
kidney failure, lower-extremity amputation, 
cardiovascular diseases and premature mortality 
(Gohdes, 1995).  
Diabetes has increasing cases in rural and 
poor populations throughout the world, despite 
major investigation into understanding  the 
pathophysiology and treatment of diabetes mellitus, 
it has continued to be a major health problem 
worldwide (Osinubi et al., 2006).The possibility of its 
management by the oral administration of 
hypoglycaemic agents has stimulated great  
research interest in recent years. Though different 
types of oral hypoglycaemic agents are available 
along with insulin for the management of diabetes 
mellitus, there was increased demand by patients 
for the use of herbal preparations with anti-diabetic 
activity (Osinubi et al., 2006).  
The use of herbal medicine was wide 
spread (Habib et al., 2005). The use of herbs has 
more than tripled over the last 10 years (Eisenberg 
et al., 1998). Estimates of use of herbal preparation 
range from 40 to 60 % among the United States 
population (Slesinski et al., 1995). The growing 
public interest and awareness of herbal medicine 
have led the pharmaceutical industry and 
biomedical researchers to pay more attention to 
medicinal plants (Day, 1998). The annual sale of 
medicinal herbs and related commodities in the 
United States now exceeds two billion dollars 
(Craig, 1999). The current shift to the use of herbal 
preparations may therefore be due to presumed 
effectiveness, relatively low cost, presumed less 
side effects and low toxicity even though the 
biologically active constituents may be often 
unknown (Osinubi et al., 2006). Recently, there has 
been a resurgent interest in the herbal treatments of 
diabetes. For a long time diabetes have been 
treated orally with several medicinal plants or their 
extracts based on herbal medicine (Akhtar and Ali, 
1984). Little scientific evidence exists to support the 
numerous herbs used to improve diabetes related 
metabolic disorder (Lo et al., 2004). The use of 
herbal products for medicinal benefits has played 
an important role in nearly every culture on earth 
and for many years, the search for anti-diabetic 
products will continue to focus on plants and other 
natural resources (Osinubi et al., 2006). The cost of 
administrating modern antidiabetic drugs was 
beyond the reach of most people in the low income 
group and those living in the rural areas, hence the 
use of plants for the treatment of common diseases 
such as diabetes are very common. Herbal 
medicine therefore can solve the economic problem 
of the poor. Investigators have consistently found 
that several plant products showed unique 
hypoglycaemic activities in diabetic animal model 
(Kusano and Abe, 2000). West Africa has several 
thousand of such plants (Gbile, 1980). Nigeria was 
blessed with medicinal plants which are used for the 
treatment of various diseases.   
In line with the WHO (1980) expert 
committee on diabetes which recommends that 
traditional methods of treatment of diabetes should 
be further investigated. Also considering the 
economic resource constraints and cheapness of 
these herbal products, this present study was 
designed to determine the effect  of  increasing  
dosage of  plant extracts  on  total  serum  
cholesterol  and total  serum  lipids of alloxan - 
induced diabetic R. novergicus for possible use of 
the most effective hypolipidaemic dosage in the 
prophylaxis and treatment of atherosclerosis  and 
hyperlipidaemia commonly found in diabetes 
mellitus. These will thus provide a pharmacological 
basis for the use of the most hypolipidaemic dosage 
of the plant extracts in adult onset Type 2 diabetes 
mellitus in some parts of Nigeria, Africa and the 
World at large. This was more so as many modern 
pharmaceuticals used in conventional medicine 
today also have natural plant origin. Example 
Metformin was derived from the flowering plant 
Galya officinalis (Goat’s Rue or French lilac) which 
was a common traditional remedy for diabetes. 
There was therefore no doubt that antidiabetic 
medicinal plant might provide an important source 
of new oral hypolipidaemic compounds for 
development as pharmaceutical entities or as 
simple dietary adjuncts to existing therapies. 
Against this background, this paper seek to 
ascertain the  comparative hypolipidaemic effects of 
Allium cepa, Allium sativum and Zingiber officinale 
aqueous extracts on alloxan-induced diabetic 
Rattus novergicus 
 
Materials and Methods 
 
 Plant material: The A. sativum, Z. officinale and A. 
cepa used for the experiment were bought from the 
Ogige market in Nsukka from a trader who has the 
health ones. The plants were identified to species 
level (Gbile, 1980) at the herbarium unit of the 
department of Botany University of Nigeria, Nsukka 
where voucher specimen were kept.  
 
Animal model: A hundred and seventeen (117) 
male adult white Wistar strain albino rats (R. 
norvegicus) weighing 200 to 250g, bred in the 
animal house of the Faculty of Veterinary Medicine, 
University of Nigeria, Nsukka were used for the 
study. They were fed ad labium with 30% crude 
protein (Guinea feed) commercial feed. They were 
allowed to acclimatize under standard photoperiodic 
condition in a clean rat cage in the Postgraduate 
Research Laboratory, Department of Zoology, 
University of Nigeria, Nsukka. All animals were 
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for temperature 26 ± 20C, humidity and light and 
were allowed free access to food and water.    
 
Extract preparation of plant materials: The 
methods of Akah et al. (2004) and Habib et al. 
(2005) were used for extraction of the aqueous 
plant extracts. Fresh health plant each of A. cepa, 
A. sativum and Z. officinale (2000g) were washed, 
cut into small pieces and homogenized in a waring 
blender. The resulting mixture was soaked in 2L of 
distilled water. The mixture was allowed to stand for 
twenty four hours with intermittent shaking. 
Following filtration, the filtrate was boiled to dryness 
over a water bath and the weight of the crude 
extract determined. The extract was kept in 
refrigerator (40 C) thereafter. The extract was later 
reconstituted in normal saline (0.85% NaCl) at a 
concentration of 1g/ml before administration on 
each day of the experiment.  
 
Induction of diabetes mellitus: The methods of 
Battu et al. (2007) and Osinubi et al. (2006) were 
used to induce diabetes in the rats. Two grams of 
crystalline powdered alloxan monohydrate was 
dissolved in 50mls of normal saline to yield a 
concentration of 40mg/ml.150mg/kg body weight of 
alloxan were administered intraperitoneally to the 
rats after overnight fast (access to only water) of 
twelve hours to make them more susceptible to 
developing diabetes. Only rats with serum glucose 
levels between (250 – 400 mg/dl) after two weeks 
were considered diabetic and used for the 
experiment.  
 
Experimental design: The study was carried out 
on alloxan- induced diabetic rats for six weeks 
(Kumari et al., 1995). The animals were fasted for 
sixteen hours before each experiment and blood 
sample collected from the eye of the rats. All 
physiological parameters assessed were 
determined before the extract treatments of the 
animals (initials) and subsequently evaluated 
weekly for six weeks. The experimental design was 
the three by three Latin square design. The hundred 
and seventeen rats used were divided into two 
major groups: Group I: nine non diabetic rats (non 
diabetic control). Group II: a hundred and eight 
alloxan induced diabetic rats.  
 The group I rats were divided into 3 
subgroups (Ia, Ib and Ic) of  3 rats each in different 
cages and receives 1.0ml of normal saline 
intraperitoneally daily. The Group II   rats (alloxan 
induced diabetic) were divided into 4 subgroups 
(IIa, IIb, IIc and IId). Subgroups IIa, IIb and IIc were 
divided into 3 replicates (IIa1, IIa2, IIa3, IIb1, IIb2, IIb3 
and IIc1, IIc2, IIc3) respectively, each replicate (3 
rats each) receiving 200 mg/kg, 250 mg/kg or 300 
mg/kg of A. cepa, A. sativum and Z. officinale 
aqueous extracts intraperitonially daily which were 
replicated thrice. The subgroups IId was the 
diabetic control (twenty- seven rats) and were 
divided into 3 replicates (IId1, IId2 and II3) each 
replicate had three rats and  were administered 
2.5mg/kg/, 3.8mg/kg and 5.0mg/kg of antidiabetic 
drug (glibenclamide).   
 
Total serum cholesterol determination: The 
cholesterol of the serum was oxidised to a tetraene 
derivative by ferric ions derived from ferric 
perchlorate, and the absorbance of the mixture at 
590 nm was read using spectrophotometer and 
compared with that of a pure solution of cholesterol 
(Sood, 1999).  
 
Total serum lipid determination: Serum 0.05ml, 
was pipetted into a test tube (15ml), containing 
2.00ml of concentration Sulphuric acid (d= 1.84). 
The tube was swirled    carefully, closed with a 
glass ball and placed in a bath of boiling water for 
10 minutes. After cooling in cold water, o.1ml was 
transferred into another test tube (15ml) containing 
2.5ml of phosphoric acid- vanillin reagent acid the 
solution was mixed carefully. The intensity of the 
pink colour that develops reaches its maximum after 
30 minutes; it begins to fade after about 50minutes. 
The absorbance of the sample was measured at 
530 or 546 nm against the blank. The amount of 
lipid was read off an analytical care, which was 
obtained by analyzing four different amounts of total 
lipid of serum. Instead of total lipids, triolein were 
used as reference material. In this case, the values 
must be multiplied by a factor of 0.76. A standard 
solution of triolein (10g/L) was used (Sood, 1999).  
 
Data analysis: The data collected were pooled and 
analyzed for their central tendencies using 
descriptive statistic, values were given as mean ± 
standard deviation of the observations. F-LSD was 
employed to test the significant differences (P < 
0.05) among treatment means. All analyses were 




Total serum lipids: The increasing dosage (200, 
250 and 300mg/kg bw ip) of A. cepa, A. sativum 
and Z.  officinale  aqueous  extracts produced   
dose-dependent, significant (P < 0.05) reductions  
in the total serum  lipids of diabetic rats  after  6 
weeks  of  treatment when  compared with that  of  
the control  rats. The comparative effects of the 
increasing dosage of   plant extracts on total serum 
lipids compared with glibenclamide and normal 
saline in alloxan diabetic and normal  rats indicated 
that A. cepa at 200mg/kg reduced total serum lipids 
by 27.7% (184.0±9.9 to 133.1±5.8) after six weeks 
of treatment (Table 1). A. cepa at 250mg/kg 
reduced total serum lipids level by 29.4% 
(183.0±7.9 to 129.7±5.7). A. cepa at 300mg/kg 
reduced the total serum lipids by 44.4 % (184.3±8.4 
to 129.7±5.7). A. sativum at 200mg/kg reduced the 
total serum lipids by 35.5% (183.6±8.8 to 
118.4±1.8). A. sativum at 250mg/kg reduced the 
serum lipids by 38.8 % (183.2±8.8 to 111.9±5.1) A. 
sativum at 300mg/kg reduced total serum lipids by 
39.5 % (183.4±8.9 to 111.0±2.6).  Z. officinale at 
200mg/kg reduced total serum lipids by 15.6% 
(183.3±8.1 to 154.9±6.4) after six weeks of 
treatment (Table 1). Z. officinale at 250mg/kg 
reduced total serum lipids by 18.0% (184.1±8.8 to 
150.9±7.9). Z. officinale at 300mg/kg reduced total 
serum lipids by 19.8 % (183.0±8.3 to 146.7±6.9).  
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Table 1: Comparative  effects  of  the   increasing  dosage  of  plant  extracts  on  total  serum  lipids  of alloxan-induced diabetic Rattus novergicus 
Total serum  lipids(mg/dl) per weeks Treatment  Dosage
WK 0 WK 1 WK 2 WK 3 WK 4 WK 5 WK 6 
% reduction 
after 6 weeks 
 NS 1.0ml        144.1±6.9 144.1±6.8 144.2±6.3 144.1±6.9 144.1±6.9 144.1±6.5 144.1±6.7 0.02
AC 200mg         
         
         
         
         
         
         
         
         
         
         
         
184.0±9.9 167.7±2.6 160.0±2.6 155.2±1.4 152.3±1.7 147.3±1.9 133.1±5.8 27.7
AC 250mg 183.0±7.9 164.3±1.9 158.0±2.6 152.8±1.9 149.3±1.3 143.9±2.2 129.7±5.7 29.4
AC 300mg 184.3±8.4 161.8±3.0 154.1±2.9 146.3±1.6 141.9±2.5 137.9±0.9 102.4±1.9 44.4
AS 200mg 183.6±8.8 165.9±2.5 152.4±6.3 39.0±3.8 130.4±3.4 123.8±2.7 118.4±1.8 35.5
AS 250mg 183.2±7.5 164.8±2.5 155.3±3.4 143.3±4.1 134.9±2.3 123.0±5.0 111.9±5.1 38.8
AS 300mg 183.4±8.9 161.6±4.8 150.4±3.3 139.6±3.9 123.4±4.3 110.6±3.4 111.0±2.6 39.5
ZO 200mg 183.4±8.1 176.3±7.0 176.1±4.7 170.6±4.3 165.8±3.0 163.8±2.0 154.9±6.4 15.6
ZO 250mg 184.1±8.8 174.7±5.1 169.4±4.8 168.4±2.1 164.8±1.1 158.7±1.9 150.9±7.9 18.0
ZO 300mg 183.0±8.3 173.0±4.0 166.9±1.5 163.7±1.4 160.3±1.2 156.1±0.8 146.7±6.9 19.8
GL 2.5mg 183.7±7.4 166.1±2.1 161.3±2.7 151.8±2.2 144.9±2.9 135.8±2.6 141.6±4.9 22.9
GL 3.8mg 183.3±7.7 164.8±2.3 158.7±2.6 154.6±2.7 141.0±1.4 137.8±3.7 133.7±3.7 27.1
GL 5.0mg 182.9±8.3 163.6±1.8 155.0±3.1 146.1±2.9 136.0±3.8 126.8±3.9 122.4±4.4 33.1
Key: Values given represent the Mean ± SD of 9 observations. Wk = weeks, NS = Normal saline represents Non Diabetic Control, AC = Allium cepa, AS = Allium sativum, ZO = Zingiber officinale 
and GL = glibenclamide represents Diabetic control. P < 0.05, F-LSD =4.42 
 
Table 2: Comparative  effect  of  the  increasing  dosage  of  plant  extracts  on  serum   cholesterol  of  alloxan-induced diabetic  Rattus   novergicus 
Total serum cholesterol(mg/dl) per weeks Treatment  Dosage
WK0     
        
WK1 WK2  WK3 WK4 WK5 WK6
% reduction 
after 6 weeks 
 NS 1.0ml 91.0±4.2 91.0±4.4 91.0±4.2 91.0±4.3 91.0±4.2 91.0±4.1 91.0±4.1 0.1
AC 200mg         
         
         
         
         
         
         
         
         
         
         
         
127.1±6.7 121.9±2.6 116.8±1.9 112.1±1.9 111.9±2.0 107.8±2.2 101.2±3.3 20.4
AC 250mg 131.0±4.4 119.4±1.9 113.4±3.4 102.6±2.4 102.6±3.5 101.6±4.7 102.2±2.3 21.9
AC 300mg 130.1±3.7 117.4±2.1 111.2±2.4 99.4±3.6 100.4±3.4 96.4±5.9 94.7±4.2 27.2
AS 200mg 129.1±5.1 120.9±1.8 114.1±1.9 111.3±2.9 102.0±4.5 94.9±5.2 83.1±3.1 35.6
AS 250mg 128.7±4.2 117.6±1.9 112.4±1.7 109.0±2.0 101.2±4.5 92.1±5.2 80.2±3.5 37.7
AS 300mg 128.2±2.7 116.7±3.4 110.8±1.7 104.3±2.8 99.3±3.0 92.4±5.2 77.2±4.9 39.8
ZO 200mg 129.1±6.0 132.2±5.6 130.4±0.4 125.7±3.5 122.3±2.9 120.2±4.7 119.4±2.9 7.5
ZO 250mg 129.4±5.6 130.3±4.1 129.4±4.1 124.1±3.4 121.8±2.4 114.6±4.6 112.7±3.9 12.9
ZO 300mg 130.7±4.4 128.2±6.0 125.2±5.1 123.2±4.5 123.0±5.2 113.0±9.5 109.7±7.5 16.1
GL 2.5mg 129.4±4.4 121.8±3.5 112.9±2.6 111.9±3.4 105.7±2.0 104.7±6.7 99.7±3.2 22.9
GL 3.8mg 129.1±4.3 119.1±2.9 110.8±2.4 105.8±2.1 101.6±3.5 97.3±2.5 91.0±3.7 29.5
GL 5.0mg 129.4±3.7 115.8±2.8 109.3±2.0 102.9±2.3 96.0±3.4 97.6±5.3 86.8±3.1 32.9
Key: Values given represent the Mean ± SD of 9 observations. WK = weeks, NS = Normal saline represents Non Diabetic Control, AC = Allium cepa, AS = Allium sativum, ZO = Zingiber officinale 
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Glibenclamide at 2mg/kg bw reduced total 
serum lipids by 22.9% (183.7±7.4 to 141.6±4.9) 
after six weeks of treatment where as at 3.8mg/kg 
reduced total serum lipids by 27.1 % (183.3±7.7 to 
133.7±3.7) (Table 1) and at 5.0mg/kg reduced total 
serum lipids by 33.1 % (182.9±8.3 to 122.4±4.4). 
The  most  effective percentage reduction in  total  
serum lipids   was  observed at 300mg/kg bw ip  
and   this  was   the  same  for the  three  extracts  
studied. Normal saline at 1ml/kg bw ip had no effect 
on total serum lipids (144.1± 6.9 to 144.1±6.7) 
(Table 1). These  values  were  statistically  different 
when  their  F-LSD  value  (4.43) was used to test  
the  significant   differences  between the  means    
(P  =  0.05).  Among  the  extracts  studied,  after  6  
weeks  of  treatment,  A. cepa at 300mg/kg bw ip  
was  the  most  effective in  reducing  total serum 
lipids. The comparative effects of the increasing 
dosage of the extracts on total serum lipids. A. cepa 
and A. sativum at 300mg/kg bw  ip  caused 
percentage reductions  in total serum lipids more 
effective than the diabetic  control drug  
glibenclamide at  5.0mg/kg bw ip  after the  6 weeks  
of  treatment. 
 
Total serum cholesterol: The increasing dosage 
(200, 250 and 300mg/kg bw ip) of A. cepa, A. 
sativum and Z.  officinale  aqueous  extracts 
produced   dose-dependent significant (P< 0.05)  
reductions  in the total serum  cholesterol of diabetic 
rats  after  6 weeks  of  treatment when  compared 
with that  of   the  control  rats. The comparative 
effects of the increasing dosage of plant extracts on 
total serum cholesterol compared with 
glibenclamide and normal saline in alloxan diabetic 
and normal rats indicated that A. cepa at 200mg/kg 
reduced total serum cholesterol by 20.4% 
(127.0±6.7 to 101.2±3.3) after six weeks of 
treatment. A. cepa at 250mg/kg reduced the serum 
cholesterol level by 21.9% (131.0±4.4 to 
102.2±2.3). A. cepa at 300mg/kg reduced the total 
serum cholesterol by 27.5 % (130.1±3.7 to 
94.7±4.2) and A. sativum at 250mg/kg reduced the 
serum cholesterol by 37.7 % (128.7±4.2 to 
80.2±3.5). A. sativum at 300mg/kg reduced total 
serum cholesterol by 39.8 % (128.7±2.7to 
77.2±4.9).  Z. officinale at 200mg/kg reduced total 
serum cholesterol by 7.5% (129.1±6.0 to 119.4±2.9) 
after six weeks of treatment.   Z. officinale at 
250mg/kg reduced total serum cholesterol by 12.9% 
(129.4±5.6 to 112.7±3.9). Z. officinale at 300mg/kg 
reduced it by 16.1 % (130.7±4.4 to 109.7±7.5) 
(Table 2). Glibenclamide at 2.5mg/kg reduced total 
serum cholesterol by 22.9% (129.4±4.4 to 99.7±3.2) 
after six weeks of treatment. Glibenclamide at 
3.8mg/kg reduced the total serum cholesterol level 
by 29.5 % (129.1±4.3 to 91.0±3.7). Glibenclamide 
at 5.0mg/kg reduced the serum cholesterol by 32.9 
% (129.4±3.7 to 86.8±3.1) (Table 2). The  most  
effective percentage reduction in  total  serum 
cholesterol   was  observed at 300mg/kg bw ip  and  
this  was  the same for the  three  extracts  studied. 
Normal  saline at 1ml/kg bw ip had no effect on the 
total serum cholesterol (91.0 ± 4.2 to 91.0 ± 
4.1).These  values  were  statistically  different 
when  their  F-LSD value   (3.67) was used to test  
for the significant   difference  between the  means  
(P = 0.05). Among the extracts studied, after 6 
weeks of treatment, A. sativum at 300mg/kg bw ip 
was  the  most  effective in  reducing  total  serum 
cholesterol  (39.8%),  A. cepa  follows  with  27.2%  
and  Z.  Officinale with 16.1% reductions. The 
comparative effects of the increasing dosage of 
plant extracts on total serum cholesterol indicated 
that A. sativum at 300mg/kg bw  ip  more  effective 
than the diabetic  control drug  glibenclamide at  
5.0mg/kg bw ip  after the  6 weeks  of  treatment in 
reduction of serum cholesterol, where  as  A. cepa  
at 300mg/kg bw ip  reduced  serum  cholesterol in a  




Alteration  in  serum   lipids  profile  are known  in  
diabetes , which are  likely  to increase  the  risk  of  
coronary  heart disease (Laakso,  1996; Steiner, 
1999; Massing et  al.,  2001). Hypercholesterolemia 
has been reported to occur in alloxan - diabetic rats 
(Sharma et al., 1996; Pushparaj   et al., 2000).  A 
significant reduction in serum cholesterol and total 
lipids as observed in this experiment (Table 1 and 
2) were in agreement with the findings of   these 
researchers.  The marked  hyperlipidaemia that  
characterizes  the  diabetic state  may  therefore  be  
regarded  as a  consequence  of  the uninhibited  
actions of  lipolytic hormones on  the fat depots 
(Hardman  and  Limberd,  2001).  S-allyl  cysteine 
sulfoxide contained in  garlic has  been  used  in 
controlling  hypercholestermia  (Dahanukar et  al .,  
2000). This  could account  for  garlic ability  to  
reduced  serum  cholesterol  and  total  serum  
lipids in  dose- dependent manner  as shown by  
the outcome of  this research work (Table 1 and 2). 
Both garlic protein  and  garlic oil  (100mg/kg b wt) 
exhibited  significant  lipid lowering  effects  in  rats  
fed  with cholesterol diet (Dahanukar  et  al ., 2000). 
The hypolipidaemic  action  was  primarily  due  to  
a  decrease  in  hepatic  cholesterogenesis  in  the  
treated  rats. These  beneficial  effects  of  garlic  
has been  reported to  be  partly  due  to  its  
inhibitory  effects on  transaminases, alkaline  
phosphatase, lipogenic  enzymes  and  HMG  COA  
reductase  and partly  due  to  stimulatory  effects  
on  plasma  lecithin  cholesterol  acid  transferase  
lipolytic   enzymes  and  fecal  excretion  of  sterols  
and  bile  acids (Dahanukar  et  al .,  2000).  It  has   
been  reported  in  rat,  chicken  and   monkey  
hepatocytes that garlic  paste, garlic  oil, allicin  and  
ajoene  significantly reduced  cholesterol 
biosynthesis  by  inhibiting  HMG COA  reductase  
and  11-alpha-demethylase (Kemper,  2000).  Some 
researchers  postulated  that  garlic’s trace  
minerals  such  as  tellurium  also  inhibited  hepatic  
cholesterol  synthesis  but  most  attribute  garlic’s  
antilipemic  effects  to  disulfide,  a decomposition  
product  of  allicin ( Kemper, 2000).  Total  lipid  
contents  and  cholesterol  levels  in  liver  were  
decreased  in  rats  after  chronic  garlic  
consumption  (Banerjee  and  Maulik, 2002). Onions  
was  becoming better  known  for  its  established  
effects  on  cholesterol  levels (Blumenthal, 1998). 
With onions proven hypocholesterlemic properties, 
onions may have a promising future in the treatment 
of diabetes and heart disease (Blumenthal, 1998). 
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Onions lowering effect on lipid profile of diabetic 
rats have been confirmed by the findings of this 
research work (Table 1 and 2). It reduced total 
serum lipids and cholesterol in a dose dependent 
manner. This  hypolipidaemic effect  of  onions  may  
be  connected  to  its  active  ingredient  allyl propyl  
disulfide (APDS) , even though other active  
sulphurous compounds  may  be  involved. Long 
term feeding of  allyl propyl disulfide  isolated  from  
onions to  normal  growing  rats led to  significant 
decreases  in  serum and liver lipids (Blumenthal,  
1998). Ginger was a cholesterol lowering herb 
(Kemper, 1999).  In  rabbit  fed  high cholesterol  
diet, ginger extracts  had antilipemic  effects  
reducing  serum cholesterol  and  high lipid  level 
(Bhandari  et  al.,  1998).  In experimental mice, 
ginger extract had significantly impaired cholesterol 
biosynthesis and lowered serum cholesterol 
concentrations (Tanabe et al., 1993).  The findings 
of this research on   hypolipidaemic effect of ginger 
(Table 1 and 2) were in line with earlier reports. The 
hypolipidaemic effect may be due to decreased 
oxidative load. It may also act by either  directly  
scavenging the reactive oxygen metabolites, due to 
the presence of  various antioxidant  compounds 
(Gupta  et al ., 2002) or  by increasing  the 
synthesis  of antioxidant molecules. The   
prevalence of  atherosclerosis  among  diabetics  
was  on the  increase  in  the  world and  recently  in  
Nigeria (Nwanjo  and Oze, 2006).  Lipid profile 
which  was altered  in serum of  diabetic  patients 
(Orchard, 1990;  Betteridge, 1994) appeared  to  be  
a  significant  factor  in  the  development  of  
premature  atherosclerosis  though   increase in 
serum triglyceride  and  total  cholesterol  levels. A  
reduction in  lipid  profile  could  be  beneficial  in  
preventing  diabetic  complications as  well  as  
improving  lipid  metabolism in  diabetics  (Cho  et  
al .,  2002). Considering extracts  effects  on lipid 
components, it  can  be assumed a potential  
hypolipidaemic  agent  which  will be  a great  
advantage  both  in  diabetic conditions  as  well as  
the  associated  atherosclerosis  or  hyperlipidaemic  
conditions. 
 
Conclusions: It  can be  concluded from this study 
that  the  levels of  total  serum  cholesterol and  
total  serum  lipids  which  were actually  raised  in  
alloxan - diabetic  rat  can  be  lowered  by  garlic , 
onions  and  ginger  aqueous  extracts. The   
hypolipidaemic effects  are thus protective 
mechanism s  against  the  development  of  
atherosclerosis and hyperlipidaemia  common  in  
diabetes  mellitus.  This  study  may  provide  a  
basis  for  dietary  supplementation  of  garlic, 
onions and  ginger  compounds  in  diabetics  to  
reduced  over  dependence on drug. A combination 
of the three plant extracts may be most effective for 
hyperlipidaemic managements. Further research on 
the combined effects of the three plant extracts on 
hyperlipidaemia was highly suggested as each of 
the three plant extracts exhibited promising 
hyperlipidaemic activity in alloxan - diabetic rats.  
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